(Q38071018)

28 August 2017

1 reference

title

Diabetes therapy--focus on Asia: second-line therapy debate: insulin/secretagogues (English)

1 reference

28 August 2017

Roy Eldor

1

1 reference

28 August 2017

Itamar Raz

series ordinal

2

1 reference

28 August 2017

publication date

1 December 2012

1 reference

Diabetes - Metabolism: Research and Reviews

28 August 2017

published in

1 reference

28 August 2017

volume

28 Suppl 2

1 reference

28 August 2017

page(s)

85-89

1 reference

Secondary failure of metformin monotherapy in clinical practice

28 August 2017

cites work

1 reference

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

21 January 2018

1 reference

A cohort study of acute pancreatitis in relation to exenatide use.

21 January 2018

1 reference

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

21 January 2018

1 reference

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

21 January 2018

1 reference

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight Gain

21 January 2018

1 reference

Central adiposity, regional fat distribution, and the risk of cholecystectomy in women

21 January 2018

1 reference

Subcutaneous fat accumulation and BMI associated with risk for pulmonary embolism in patients with proximal deep vein thrombosis: a population study based on 23 796 consecutive autopsies

21 January 2018

1 reference

Obesity, weight gain, and the risk of kidney stones

21 January 2018

1 reference

Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study

21 January 2018

1 reference

Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria

21 January 2018

1 reference

Appropriate BMI for Asian populations

21 January 2018

1 reference

Association between serious ischemic cardiac outcomes and medications used to treat diabetes

21 January 2018

1 reference

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation.

21 January 2018

1 reference

Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire

21 January 2018

1 reference

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).

21 January 2018

1 reference

Sulfonylurea induced beta-cell apoptosis in cultured human islets

21 January 2018

1 reference

Exendin-4 protects against sulfonylurea-induced β-cell apoptosis

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.

21 January 2018

1 reference

Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits

21 January 2018

1 reference

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

21 January 2018

1 reference

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction

21 January 2018

1 reference

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine

21 January 2018

1 reference

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.

21 January 2018

1 reference

Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey.

21 January 2018

1 reference

Insulin-associated weight gain in diabetes--causes, effects and coping strategies

21 January 2018

1 reference

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

21 January 2018

1 reference

Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia

21 January 2018

1 reference

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

21 January 2018

1 reference

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

21 January 2018

1 reference

Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients

21 January 2018

1 reference

Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy

21 January 2018

1 reference

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

21 January 2018

1 reference

Self-management support for insulin therapy in type 2 diabetes

21 January 2018

1 reference

Nonadherence to insulin therapy in low-income, type 2 diabetic patients.

21 January 2018

1 reference

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia.

21 January 2018

1 reference

Sulfonylurea and glinide reduce insulin content, functional expression of KATP channels, and accelerate apoptotic β-cell death in the chronic phase

21 January 2018

1 reference

Coronary heart disease outcomes in patients receiving antidiabetic agents

21 January 2018

1 reference

7 January 2021

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

1 reference

7 January 2021

Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial

1 reference

7 January 2021

Weight gain and insulin treatment

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2358

1 reference

28 August 2017

1 reference